{"transactions":[{"id":844342,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-13T20:19:48.000Z","date":"2026-03-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 11, 2026), with the final monthly installment vesting no later than the nearest trading day on the Nasdaq Global Select Market preceding the 2027 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":14.17,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0002064832-26-000142","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483226000142/form4.xml","form_type":"4"}},{"id":1206009,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-14T21:43:30.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 13, 2025), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2026 annual meeting of stockholders."}],"balance_after":15700,"derivative":{"exercise_price":6.83,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001062993-25-005506","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299325005506/form4.xml","form_type":"4"}},{"id":1587270,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T22:27:40.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 6, 2024), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2025 annual meeting of stockholders."}],"balance_after":15700,"derivative":{"exercise_price":15.66,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001062993-24-006050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299324006050/form4.xml","form_type":"4"}},{"id":1969565,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T22:20:24.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 2, 2023), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2024 annual meeting of stockholders."}],"balance_after":10800,"derivative":{"exercise_price":47.72,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001062993-23-006095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299323006095/form4.xml","form_type":"4"}},{"id":2348399,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T23:50:18.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 3, 2022), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2023 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":68.22,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001062993-22-007011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299322007011/form4.xml","form_type":"4"}},{"id":2809239,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-04T23:37:29.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 2, 2021), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2022 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":49.92,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001177648-21-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764821000017/edgar.xml","form_type":"4"}},{"id":3241498,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-28T22:18:51.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 26, 2020), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2021 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":51.04,"expiration_date":"2030-02-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001177648-20-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764820000018/edgar.xml","form_type":"4"}},{"id":3623461,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-02T01:06:11.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 28, 2019), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2020 annual meeting of stockholders."}],"balance_after":5000,"derivative":{"exercise_price":102.54,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001177648-19-000023","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764819000023/edgar.xml","form_type":"4"}},{"id":3720926,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":19500,"price":13.19,"value":257205.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Company stock option was scheduled to vest 100% on the business day prior to the Company's annual stockholder meeting following May 3, 2018. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Company stock option was scheduled to vest 100% on the business day prior to the Company's annual stockholder meeting following May 3, 2018. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720925,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":19500,"price":21.73,"value":423735.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":2.27,"expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720924,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":13500,"price":20.65,"value":278775.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.35,"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720923,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":13500,"price":17.98,"value":242730.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.02,"expiration_date":"2025-05-14","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720922,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":14000,"price":17.31,"value":242340.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.69,"expiration_date":"2024-05-15","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720921,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":14000,"price":11.06,"value":154840.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":12.94,"expiration_date":"2023-06-19","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720920,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":28000,"price":14.37,"value":402360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":9.63,"expiration_date":"2023-01-04","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720919,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":3300,"price":24,"value":79200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This restricted stock unit (\"RSU\") award provided for vesting and settlement 100% on the business day prior to the Company's annual stockholder meeting following May 3, 2018 in the form of one share of Company common stock for each RSU. Pursuant to the Merger Agreement, at the Effective Time, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to $24.00, multiplied by the number of shares of Company common stock subject to such RSU, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3720918,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T12:52:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":7800,"price":24,"value":187200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 17, 2018 (the \"Merger Agreement\"), by and among Endocyte, Inc. (the \"Company\"), Novartis AG (\"Novartis\") and Edinburgh Merger Corporation, a wholly owned subsidiary of Novartis (\"Merger Sub\"), at the effective time (the \"Effective Time\") of the merger of Merger Sub with and into the Company, which Effective Time occurred on December 21, 2018, each share of Company common stock was converted into the right to receive an amount in cash equal to $24.00, without interest and less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074353","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074353/a4.xml","form_type":"4"}},{"id":3900929,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T16:11:46.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":7543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders."}],"balance_after":7543,"derivative":{"exercise_price":24.45,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":7543},"source":{"system":"sec-edgar","filing":"0000792977-18-000042","document":"wf-form4_152848867319627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000042/wf-form4_152848867319627.xml","form_type":"4"}},{"id":3900928,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T16:11:46.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":3578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":24913,"source":{"system":"sec-edgar","filing":"0000792977-18-000042","document":"wf-form4_152848867319627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000042/wf-form4_152848867319627.xml","form_type":"4"}},{"id":3945390,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-04T17:04:13.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of options vest on the business day prior to the next annual stockholder meeting following the date of grant."}],"balance_after":19500,"derivative":{"exercise_price":10.81,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001179110-18-006313","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018006313/edgar.xml","form_type":"4"}},{"id":3945389,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-04T17:04:13.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest 100% on the business day prior to the next annual stockholder meeting following the date of grant, and will be paid in the form of one share of common stock for each restricted stock unit."}],"balance_after":11100,"source":{"system":"sec-edgar","filing":"0001179110-18-006313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018006313/edgar.xml","form_type":"4"}},{"id":4015865,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-06T00:31:54.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 28, 2018), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2019 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":78.62,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001177648-18-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000017/edgar.xml","form_type":"4"}},{"id":4250737,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T19:02:28.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":185500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 185,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 185,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 185,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 185,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.12,"expiration_date":"2026-04-18","underlying":"Ordinary Shares, par value $0.01 per share","underlying_shares":185500},"source":{"system":"sec-edgar","filing":"0001144204-17-038443","document":"v471494_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374636/000114420417038443/v471494_4.xml","form_type":"4"}},{"id":4250736,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-07-26T19:02:28.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":187142,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Immediately prior to the Effective Time (as defined below), the Reporting Person beneficially owned (i) 7,142 ordinary shares of the Issuer, par value $0.01 per share (\"Ordinary Shares\") , and (ii) 180,000 restricted stock units (\"RSUs\") issued under the Issuer's 2016 Omnibus Incentive Compensation Plan (the \"Plan\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Transaction Agreement by and among the Issuer, Gurnet Point L.P., a Delaware limited partnership acting through its general partner Waypoint International GP LLC (\"Gurnet Point\"), and Lough Ree Technologies Limited, an Irish private limited company and wholly-owned subsidiary of Gurnet Point (the \"Transaction Agreement\"), each Ordinary Share that was beneficially owned by the Reporting Person immediately prior to the effective time of the scheme (the \"Effective Time\") now represents the right to receive (i) $1.75 in cash and (ii) a contingent value right which represents a contractual right to receive payments up to a maximum aggregate amount of $4.90 in cash upon, and subject to, the occurrence of certain events, without interest and net of applicable tax withholdings (the \"Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Transaction Agreement, each RSU that was beneficially owned by the Reporting Person immediately prior to the Effective Time, was cancelled and now represents the right to receive the Consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to the terms of the Transaction Agreement by and among the Issuer, Gurnet Point L.P., a Delaware limited partnership acting through its general partner Waypoint International GP LLC (\"Gurnet Point\"), and Lough Ree Technologies Limited, an Irish private limited company and wholly-owned subsidiary of Gurnet Point (the \"Transaction Agreement\"), each Ordinary Share that was beneficially owned by the Reporting Person immediately prior to the effective time of the scheme (the \"Effective Time\") now represents the right to receive (i) $1.75 in cash and (ii) a contingent value right which represents a contractual right to receive payments up to a maximum aggregate amount of $4.90 in cash upon, and subject to, the occurrence of certain events, without interest and net of applicable tax withholdings (the \"Consideration\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Pursuant to the terms of the Transaction Agreement, each RSU that was beneficially owned by the Reporting Person immediately prior to the Effective Time, was cancelled and now represents the right to receive the Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-038443","document":"v471494_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374636/000114420417038443/v471494_4.xml","form_type":"4"}},{"id":4310944,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T19:10:35.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":10110,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders."}],"balance_after":10110,"derivative":{"exercise_price":19.25,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10110},"source":{"system":"sec-edgar","filing":"0001179110-17-007787","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017007787/edgar.xml","form_type":"4"}},{"id":4310943,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T19:10:35.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":4545,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":21335,"source":{"system":"sec-edgar","filing":"0001179110-17-007787","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017007787/edgar.xml","form_type":"4"}},{"id":4331605,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-05T17:08:25.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of options vest on the business day prior to the next annual stockholder meeting following the date of grant."}],"balance_after":19500,"derivative":{"exercise_price":2.27,"expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001179110-17-006713","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017006713/edgar.xml","form_type":"4"}},{"id":4331604,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T17:08:25.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest 100% on the business day prior to the next annual stockholder meeting following the date of grant, and will be paid in the form of one share of common stock for each restricted stock unit."}],"balance_after":7800,"source":{"system":"sec-edgar","filing":"0001179110-17-006713","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017006713/edgar.xml","form_type":"4"}},{"id":4436285,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-22T00:46:11.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option became and will become exercisable monthly in substantially equal installments over three years, beginning from November 18, 2016."}],"balance_after":2500,"derivative":{"exercise_price":29.02,"expiration_date":"2026-11-18","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001177648-17-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764817000020/edgar.xml","form_type":"4"}},{"id":4545263,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61041,"kind":"person","name":"Russell Lesley","position":1,"cik":"0001374636","reported_name":"Russell Lesley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-11-22T22:44:26.000Z","date":"2016-11-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over three years, beginning from the date of grant (November 18, 2016)."}],"balance_after":10000,"derivative":{"exercise_price":30,"expiration_date":"2026-11-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001177648-16-000005","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764816000005/edgar.xml","form_type":"4"}}]}